Literature DB >> 9877281

Low levels of ionic mercury modulate protein tyrosine phosphorylation in lymphocytes.

A J Rosenspire1, S Bodepudi, M Mathews, M J McCabe.   

Abstract

The ability of ionic mercury to induce protein tyrosine phosphorylation in mouse spleen cells and in the mouse WEHI-231 B-cell lymphoma was investigated. We have confirmed previous studies which showed that exposure to high levels (several hundred microM) of mercury lead to very large increases in the level of protein tyrosine phosphorylation in these cell systems. However we have also demonstrated that low levels (in the order of 0.1 to 1.0 microM) of mercury also significantly upregulate protein tyrosine phosphorylation. Mercury induced protein tyrosine phosphorylation is inhibited by the mercury chelator penicillamine and by pretreating treating target cells with the sulfhydryl blocking reagent N-hydroxymaleimide. These results suggest that exposure to low levels of mercury could potentially interfere with lymphocyte signal transduction and so offer a possible explanation as to how mercury exposure could lead to immune cellular dysfunction. On a molecular level, the results suggest that the site(s) of action with respect to mercury dependent induction of protein tyrosine phosphorylation is likely a free disulfide group or groups located on the outer leaflet of the plasma membrane.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9877281     DOI: 10.1016/s0192-0561(98)00045-9

Source DB:  PubMed          Journal:  Int J Immunopharmacol        ISSN: 0192-0561


  2 in total

Review 1.  Mercury-induced inflammation and autoimmunity.

Authors:  K Michael Pollard; David M Cauvi; Christopher B Toomey; Per Hultman; Dwight H Kono
Journal:  Biochim Biophys Acta Gen Subj       Date:  2019-02-10       Impact factor: 3.770

2.  Low level exposure to inorganic mercury interferes with B cell receptor signaling in transitional type 1 B cells.

Authors:  R Gill; M J McCabe; A J Rosenspire
Journal:  Toxicol Appl Pharmacol       Date:  2017-06-28       Impact factor: 4.219

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.